15.6 Bacterial Role in Disease
Key Takeaways
- Virulence factors include capsules (antiphagocytic), toxins (endotoxin and exotoxins), enzymes (hyaluronidase, coagulase, lecithinase), and antigenic variation
- Endotoxin (lipopolysaccharide) is an integral part of the Gram-negative outer membrane and activates TLR4, causing fever, hypotension, DIC, and shock when released
- Exotoxins are secreted proteins with specific targets (e.g., diphtheria toxin ADP-ribosylates EF-2; botulinum toxin cleaves SNARE proteins) and are often encoded by bacteriophages
- The PA-CAT sample item illustrates molecular mimicry: Streptococcus pyogenes M protein and cell-wall antigens cross-react with heart and joint tissue, causing rheumatic fever after untreated pharyngitis
- Antibiotic resistance mechanisms include altered targets (PBP2a in MRSA, D-Ala-D-Lac in VRE), enzymatic inactivation (beta-lactamases, aminoglycoside-modifying enzymes), and efflux pumps
Pathogenesis: The Chain of Infection
Bacterial disease requires a sequence: encounter → entry → adherence → evasion → multiplication → damage → exit. Each step has a corresponding virulence factor, and the PA-CAT Bulletin of Information, rev. 20240815, expects you to connect specific factors to clinical syndromes. The PA-CAT sample item — a 13-year-old with sore throat followed by a rash with pink rings and clear centers and elevated ASO antibodies — points to Streptococcus pyogenes (Group A strep) causing rheumatic fever, an archetype of immune-mediated post-infectious disease.
Virulence Factors at a Glance
Capsules
A capsule is an extracellular polysaccharide (or polypeptide, in Bacillus anthracis) layer that resists phagocytosis by blocking complement deposition and opsonin recognition. Encapsulated organisms — S. pneumoniae, N. meningitidis, H. influenzae type b, Klebsiella, B. anthracis — cause invasive disease when capsule is present and are controlled by capsule-specific antibody (basis of conjugate vaccines).
Toxins: Endotoxin vs. Exotoxin
| Feature | Endotoxin (LPS) | Exotoxin |
|---|---|---|
| Source | Gram-negative outer membrane | Secreted by Gram-positive or Gram-negative |
| Chemistry | Lipopolysaccharide (lipid A) | Protein (often A-B structure) |
| Heat stability | Stable (boiling) | Labile (mostly) |
| Release | On cell lysis | Active secretion |
| Mechanism | TLR4 activation → TNF, IL-1, IL-6; complement and coagulation cascades | Specific targets (ribosome, SNARE, adenylyl cyclase, Rho) |
| Disease | Sepsis, septic shock, DIC, fever | Diphtheria, tetanus, botulism, cholera, anthrax, toxic shock, pseudomembranous colitis |
| Toxoid vaccine? | No | Yes (tetanus, diphtheria, acellular pertussis) |
Endotoxin Pathophysiology
Lipid A of LPS binds LPS-binding protein (LBP) in plasma, which transfers it to CD14/MD2 on macrophages and monocytes, activating TLR4. The resulting cytokine storm — TNF-α, IL-1, IL-6 — produces fever, hypotension, capillary leak, myocardial depression, disseminated intravascular coagulation (DIC), and multi-organ failure. The hallmark lab finding of DIC is prolonged PT/PTT, low fibrinogen, elevated D-dimer, and microangiopathic hemolytic anemia with schistocytes.
Major Exotoxins You Must Know
| Organism | Toxin | Mechanism | Effect |
|---|---|---|---|
| Corynebacterium diphtheriae | Diphtheria toxin | ADP-ribosylates EF-2 | Blocks protein synthesis; pharyngeal pseudomembrane, myocarditis |
| Pseudomonas aeruginosa | Exotoxin A | ADP-ribosylates EF-2 | Same target as diphtheria |
| Vibrio cholerae | Cholera toxin | ADP-ribosylates Gsα → ↑cAMP | Massive secretory diarrhea |
| E. coli (ETEC) | Heat-labile toxin | ADP-ribosylates Gsα | Traveler's diarrhea |
| Bordetella pertussis | Pertussis toxin | ADP-ribosylates Gi → ↑cAMP | Whoop, lymphocytosis |
| Bacillus anthracis | Edema factor (calmodulin-dependent adenylyl cyclase) + lethal factor (protease) | ↑cAMP; cleaves MAP kinases | Edema, hemorrhage, shock |
| Clostridium perfringens | Alpha-toxin (lecithinase) | Cleaves phosphatidylcholine | Gas gangrene, hemolysis |
| C. tetani | Tetanospasmin | Cleaves synaptobrevin in inhibitory neurons | Spastic paralysis |
| C. botulinum | Botulinum toxin | Cleaves SNARE (synaptobrevin, SNAP-25, syntaxin) | Flaccid paralysis |
| Staphylococcus aureus | TSST-1 | Superantigen; binds MHC II and TCR Vβ | Toxic shock syndrome |
| S. aureus | Enterotoxins (A–E) | Heat-stable; superantigen | Food poisoning (rapid vomiting) |
| Streptococcus pyogenes | Streptolysin O and S | Hemolysins; pore-forming | Beta hemolysis |
| S. pyogenes | Pyrogenic exotoxins (SpeA, SpeC) | Superantigen | Scarlet fever, streptococcal TSS |
| Shigella dysenteriae | Shiga toxin | Cleaves 28S rRNA | Dysentery, HUS |
| E. coli O157:H7 | Shiga-like toxin | Cleaves 28S rRNA | HUS |
Enzymes and Tissue Invasion
- Coagulase (S. aureus) — forms fibrin clot, walling off infection.
- Hyaluronidase (S. pyogenes, Clostridium) — 'spreading factor' hydrolyzes connective tissue ground substance.
- Streptokinase/staphylokinase — activate plasminogen, dissolving clots and aiding spread.
- Lecithinase (alpha-toxin) — C. perfringens membrane destruction.
- IgA protease — N. gonorrhoeae, N. meningitidis, H. influenzae, S. pneumoniae cleave secretory IgA.
- Urease — Proteus, H. pylori, Klebsiella; raises local pH (struvite stones in Proteus).
- DNase — S. pyogenes reduces pus viscosity.
The S. pyogenes – Rheumatic Fever Connection (PA-CAT Sample Item)
The PA-CAT Bulletin of Information, rev. 20240815, sample item describes a 13-year-old with sore throat, rash with pink rings and clear centers (erythema marginatum), and ASO antibodies. This is acute rheumatic fever (ARF) — a nonsuppurative sequela of Group A strep pharyngitis occurring 2–3 weeks after untreated infection. The mechanism is molecular mimicry:
- M protein on S. pyogenes shares epitopes with cardiac myosin and sarcolemmal membrane proteins.
- Anti-M antibodies cross-react with heart tissue, producing pancarditis (endocarditis, myocarditis, pericarditis).
- The mitral valve is most commonly damaged (mitral regurgitation acutely, mitral stenosis chronically).
- Cross-reactivity with joint synovium and basal ganglia explains polyarthritis and Sydenham chorea.
Modified Jones Criteria
Diagnosis requires evidence of preceding GAS infection (positive throat culture/NAAT or rising ASO/anti-DNase B titer) plus:
| Major | Minor |
|---|---|
| Carditis | Fever |
| Polyarthritis (migratory) | Arthralgia |
| Chorea (Sydenham) | Elevated ESR/CRP |
| Erythema marginatum | Prolonged PR interval |
| Subcutaneous nodules | Prior rheumatic fever |
Two major OR one major + two minor establish the diagnosis. Primary prevention is prompt treatment of GAS pharyngitis with penicillin; secondary prevention is continuous prophylaxis (penicillin V or benzathine penicillin G monthly) for years after an ARF episode to prevent recurrence.
Contrast: Post-Streptococcal Glomerulonephritis (PSGN)
PSGN follows pharyngeal or skin GAS infection (1–3 weeks), occurs mainly in children, and is caused by immune complex deposition in glomeruli (subepithelial 'humps' on biopsy). Presents with edema, hypertension, hematuria (smoky urine), and low complement (C3). Unlike rheumatic fever, PSGN does not recur and is not prevented by penicillin prophylaxis.
| Feature | Rheumatic fever | PSGN |
|---|---|---|
| GAS site | Pharynx | Pharynx or skin |
| Latent period | 2–3 weeks | 1–3 weeks |
| Mechanism | Molecular mimicry (anti-M) | Immune complex deposition |
| Complement | Normal | Low C3 |
| Recurrence | Yes (needs prophylaxis) | No |
| Key organ | Heart (mitral valve) | Kidney (glomerulus) |
Biofilms and Quorum Sensing
Biofilms are structured communities of bacteria encased in a self-produced extracellular matrix. They form on catheters, prosthetic joints, heart valves, and in CF airways (Pseudomonas alginate). Bacteria within biofilms are 10–1000× more antibiotic-resistant than planktonic cells due to slow growth, reduced penetration, and persister cells. Quorum sensing — density-dependent gene regulation via autoinducers (acyl-homoserine lactones in Gram-negatives, oligopeptides in Gram-positives) — coordinates virulence expression.
Antimicrobial Resistance Mechanisms
| Mechanism | Example |
|---|---|
| Altered target | PBP2a (MRSA); D-Ala-D-Lac (VRE); mutated RNA polymerase (rifampin resistance in M. tuberculosis) |
| Enzymatic inactivation | Beta-lactamases (TEM, SHV, CTX-M, KPC, NDM); aminoglycoside-modifying enzymes |
| Efflux pumps | Tet efflux (tetracycline); MexAB-OprM (Pseudomonas) |
| Decreased permeability | Porin loss (OprD) in Pseudomonas → carbapenem resistance |
| Bypass pathway | Alternative DHFR in trimethoprim resistance |
Extended-spectrum beta-lactamases (ESBLs) hydrolyze penicillins, cephalosporins, and monobactams (not carbapenems) — carbapenems are the treatment of choice. Carbapenemases (KPC, NDM-1) hydrolyze carbapenems and force the use of colistin or ceftazidime-avibactam.
A 13-year-old presents two weeks after an untreated sore throat with migratory polyarthritis, subcutaneous nodules, and a rash of pink rings with clear centers. ASO titer is elevated. Which pathogenetic mechanism explains the cardiac damage in rheumatic fever?
Which toxin-organism pairing and mechanism are correctly matched?
A Gram-negative bacterium releases a heat-stable molecule on cell lysis that activates TLR4, producing fever, hypotension, and DIC. What is the active moiety and its location?